Researchers from Harvard Medical School have developed an AI model, Clinical Histopathology Imaging Evaluation Foundation (CHIEF), which can analyse multiple forms of cancer with great versatility and accuracy. CHIEF can predict patient outcomes and validate its results across different international groups. Unlike similar models based on pathology images, the system can predict patient outcomes and validate results across various patient groups. The model works by reading digital slides of tumour tissues, identifying genes and DNA patterns related to treatment responses.
Top 12 Risk Assessment Tools for Cyber Security Expected to Dominate in 2025
Hey there, Bay Area friends! Let’s raise a virtual toast to another beautiful day in our city by the bay. Ever noticed the rising tide
